Identification and molecular analysis of superoxide dismutase isoforms in Helicobacter pylori.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 10675591)

Published in FEMS Microbiol Lett on February 15, 2000

Authors

S Bereswill1, O Neuner, S Strobel, M Kist

Author Affiliations

1: University of Freiburg, Institute of Medical Microbiology and Hygiene, Department of Microbiology and Hygiene, Hermann-Herder-Str. 11, D-79104, Freiburg, Germany. bereswil@sun11.ukl.uni-freiburg.de

Articles by these authors

Immunodeficiency presenting as hypergammaglobulinaemia with IgG2 subclass deficiency. Lancet (1992) 3.45

Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr (2000) 3.35

Allelic diversity and recombination in Campylobacter jejuni. J Bacteriol (2001) 2.61

Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology (1982) 2.50

Dietary products used in infants for treatment and prevention of food allergy. Joint Statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. Arch Dis Child (1999) 2.32

Antibody response of patients against a 120 kDa surface protein of Campylobacter pylori. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 2.18

Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper. European Society of Pediatric Allergy and Clinical Immunology. Pediatr Allergy Immunol (1993) 2.17

Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report. Allergy (2008) 2.12

Effects of a few food diet in attention deficit disorder. Arch Dis Child (1993) 2.12

Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol (1981) 2.11

Comment on antigen-reduced infant formulae. ESPGAN Committee on Nutrition. Acta Paediatr (1993) 2.04

Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology (1983) 1.99

Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem (2000) 1.97

Characterization of pili associated with Escherichia coli O18ac. Infect Immun (1980) 1.80

Purification of Helicobacter pylori superoxide dismutase and cloning and sequencing of the gene. Infect Immun (1993) 1.78

Regulation of ferritin-mediated cytoplasmic iron storage by the ferric uptake regulator homolog (Fur) of Helicobacter pylori. J Bacteriol (2000) 1.66

Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg (1993) 1.62

Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62

Immune responses to fed protein antigens in mice. 3. Systemic tolerance or priming is related to age at which antigen is first encountered. Pediatr Res (1984) 1.60

Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level. Infect Immun (2001) 1.59

Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation. Infect Immun (1998) 1.58

Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53

Identification and analysis of a new vacA genotype variant of Helicobacter pylori in different patient groups in Germany. J Clin Microbiol (1998) 1.51

Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum. Gut (1984) 1.49

Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis (2000) 1.45

Bacterial genetic fingerprint: a reliable factor in the study of the epidemiology of human campylobacter enteritis? J Clin Microbiol (2001) 1.44

Folding of maltose-binding protein. Evidence for the identity of the rate-determining step in vivo and in vitro. J Biol Chem (1993) 1.37

Serodiagnosis of Helicobacter pylori infections with an enzyme immunoassay using the chromatographically purified 120 kilodalton protein. Eur J Clin Microbiol Infect Dis (1992) 1.35

Isolation of Helicobacter pullorum from patients with enteritis. Scand J Infect Dis (1997) 1.34

Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol (2001) 1.32

S3-guideline "helicobacter pylori and gastroduodenal ulcer disease" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF-registration-no. 021 / 001. Z Gastroenterol (2009) 1.27

Molecular analysis of riboflavin synthesis genes in Bartonella henselae and use of the ribC gene for differentiation of Bartonella species by PCR. J Clin Microbiol (1999) 1.26

The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol (1990) 1.19

A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J Immunol (1997) 1.17

Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy (2005) 1.17

Cloning and characterization of the fur gene from Helicobacter pylori. FEMS Microbiol Lett (1998) 1.14

The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res (2002) 1.13

Identification of iron-regulated genes of Helicobacter pylori by a modified fur titration assay (FURTA-Hp). FEMS Microbiol Lett (2000) 1.12

Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill (2008) 1.12

Structural, functional and mutational analysis of the pfr gene encoding a ferritin from Helicobacter pylori. Microbiology (1998) 1.11

Prognosis of chronic granulomatous disease. Arch Dis Child (1990) 1.09

Structural and functional analysis of the riboflavin synthesis genes encoding GTP cyclohydrolase II (ribA), DHBP synthase (ribBA), riboflavin synthase (ribC), and riboflavin deaminase/reductase (ribD) from Helicobacter pylori strain P1. FEMS Microbiol Lett (2000) 1.09

Elevated risk of Helicobacter pylori infection in submarine crews. Eur J Clin Microbiol Infect Dis (1992) 1.09

Human intestinal mucosal mast cells: expanded population in untreated coeliac disease. Gut (1983) 1.08

Noonan's and DiGeorge syndromes with monosomy 22q11. Arch Dis Child (1993) 1.08

A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther (2005) 1.06

Definitive diagnosis of nut allergy. Arch Dis Child (2000) 1.06

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes. Diabetologia (2005) 1.06

The ferric uptake regulator (Fur) homologue of Helicobacter pylori: functional analysis of the coding gene and controlled production of the recombinant protein in Escherichia coli. Med Microbiol Immunol (1999) 1.02

Effects of brief early exposure to partially hydrolyzed and whole cow milk proteins. J Pediatr (1992) 1.01

Seroepidemiological study of the immune response to Campylobacter pylori in potential risk groups. Eur J Clin Microbiol Infect Dis (1989) 1.00

Conjunctival infestation of a child with Theromyzon tessulatum. Br J Ophthalmol (1998) 1.00

Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunology (1987) 0.99

In situ localization of the 60 k protein of Helicobacter pylori, which belongs to the family of heat shock proteins, by immuno-electron microscopy. Zentralbl Bakteriol (1993) 0.98

Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child (1996) 0.98

The role of Helicobacter pylori virulence factors in interleukin production by monocytic cells. FEMS Microbiol Lett (2001) 0.98

Cryptosporidia in immunocompetent patients with gastroenteritis. Eur J Clin Microbiol (1987) 0.97

The kinetics of oral hyposensitization to a protein antigen are determined by immune status and the timing, dose and frequency of antigen administration. Immunology (1989) 0.97

[S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease"]. Z Gastroenterol (2009) 0.96

Modulation of intestinal and systemic immune responses to a fed protein antigen, in mice. Gut (1986) 0.96

T-cell mediated immunity in food allergy. Ann Allergy (1983) 0.95

Successful bone marrow transplantation and treatment of BCG infection in two patients with severe combined immunodeficiency. Eur J Pediatr (1991) 0.95

Modulation of antigen trafficking to MHC class II-positive late endosomes of enterocytes. Gastroenterology (2000) 0.95

Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis. Metabolism (2003) 0.94

Discrimination of Helicobacter pullorum and Campylobacter lari by analysis of whole cell fatty acid extracts. FEMS Microbiol Lett (1998) 0.93

Identification of environmental stress-regulated genes in Helicobacter pylori by a lacZ reporter gene fusion system. Helicobacter (2001) 0.93

Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review. Arch Dis Child (1994) 0.93

Recognition of Clostridium difficile PCR-ribotypes 001, 027 and 126/078 using an extended MALDI-TOF MS system. Eur J Clin Microbiol Infect Dis (2011) 0.92

Impact of ELISA and immunoblot as diagnostic tools one year after eradication of Helicobacter pylori in a multicentre treatment study. FEMS Immunol Med Microbiol (1999) 0.92

[Networks of National Reference Centers and associated Consiliary Laboratories in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2012) 0.91

Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol (2000) 0.90

[Infections caused by Campylobacter jejuni/coli]. Dtsch Med Wochenschr (1983) 0.90

Irradiated mice lose the capacity to 'process' fed antigen for systemic tolerance of delayed-type hypersensitivity. Clin Exp Immunol (1987) 0.90

[Establishment of Networks of National Reference Centres and associated Consiliary Laboratories in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2009) 0.90

Non-responders to hepatitis B vaccination: a review. Commun Dis Public Health (2003) 0.89

Growth, development and differentiation: a functional food science approach. Br J Nutr (1998) 0.88

Short stature/short limb skeletal dysplasia with severe combined immunodeficiency and bowing of the femora: report of two patients and review. J Med Genet (1991) 0.88

Detection of antibodies against Campylobacter jejuni serogroup PEN O:19 purified flagellar protein in a patient with Guillain-Barré syndrome. Zentralbl Bakteriol (1999) 0.87

Prevention of oral tolerance induction to ovalbumin and enhanced antigen presentation during a graft-versus-host reaction in mice. Immunology (1985) 0.87

Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: a role for a functioning gut-associated lymphoid system. Immunology (1994) 0.87

Association of ciprofloxacin prescriptions to outpatients to Clostridium difficile infections. Euro Surveill (2010) 0.87

[Who discovered Campylobacter jejuni/coli? A review of hitherto disregarded literature]. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.86

Seasonality of Clostridium difficile infections in Southern Germany. Epidemiol Infect (2011) 0.86

Leucocyte adhesion deficiency. Arch Dis Child (1993) 0.86

Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. Aliment Pharmacol Ther (2003) 0.86

Haemophagocytic lymphohistiocytosis: experience at two U.K. centres. Br J Haematol (1994) 0.86

Patterns of food allergen-specific cytokine production by T lymphocytes of children with multiple allergies. Clin Exp Allergy (2005) 0.85

Dual meningoencephalitis with echovirus type 11 and adenovirus in combined (common variable) immunodeficiency. Pediatr Infect Dis J (1988) 0.85

Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets. Exp Clin Endocrinol Diabetes (2005) 0.85

New approaches for genotyping of Helicobacter pylori based on amplification of polymorphisms in intergenic DNA regions and at the insertion site of the cag pathogenicity island. Med Microbiol Immunol (2000) 0.85

Gluten intolerance (coeliac disease). Ann Allergy (1984) 0.85

Immunological reaction of guinea-pigs following intranasal Mycoplasma pneumoniae infection and immunization with the 168 kDa adherence protein. J Gen Microbiol (1988) 0.85

Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration. Helicobacter (2000) 0.85

Mechanisms of lymphocyte adhesion to endothelial cells: studies using a LFA-1-deficient cell line. Immunology (1989) 0.84

Failure to induce oral tolerance to protein antigens in neonatal mice can be corrected by transfer of adult spleen cells. Pediatr Res (1989) 0.84